Our group previously investigated the expression of MAGE-A10 and -A11 in breast cancers and showed that they were tumor-specific antigens and that MAGE-A11 expression was a prognostic factor for a poor patient outcome (26). Here, MAGEA11 is linked to breast carcinoma.